4//SEC Filing
Thompson David E. 4
Accession 0001209191-10-048891
CIK 0001316175other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:42 PM ET
Size
5.8 KB
Accession
0001209191-10-048891
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2010-09-30+12,000→ 12,000 totalExercise: $4.19Exp: 2020-09-30→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period from July 9, 2010.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeother
Related Parties
1- filerCIK 0001484500
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 8:42 PM ET
- Size
- 5.8 KB